fon-2021-0176_Infographics.pdf (512.1 kB)
Download fileInfographic. KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma
figure
posted on 2021-05-20, 09:32 authored by Josep Tabernero, Yung-Jue Bang, Eric Van Cutsem, Charles S Fuchs, Yelena Yuriy Janjigian, Pooja Bhagia, Kan Li, David Adelberg, Shu Kui QinInfographic summary of the article ‘KEYNOTE-859: a Phase III study of pembrolizumab plus chemotherapy in gastric/gastroesophageal junction adenocarcinoma’
